VHL Antibody
Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL gene is the basis of familial inheritance of VHL syndrome. The protein is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein.
Product Specifications
CAS Number
9007-83-4
Specifications
Western blot: 1:1000, IHC (Paraffin) : 1:50-1:100, Flow Cytometry: 1:10-1:50
UniProt
P40337
Host
Rabbit
Reactivity
Human
Immunogen
A portion of amino acids 181-210 from the human protein was used as the immunogen for this VHL antibody.
Clonality
Polyclonal
Isotype
Ig
Applications
IHC, FACS, WB, ELISA
Purity
Purified
Format
Purified
Buffer
In 1X PBS, pH 7.4, with 0.09% sodium azide
Reconstitution
Aliquot the VHL antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitations
This VHL antibody is available for research use only.
Storage Conditions
Aliquot the VHL antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
Formulation
In 1X PBS, pH 7.4, with 0.09% sodium azide
Applications Notes
Titration of the VHL antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Image Legend
Western blot analysis of VHL antibody and HepG2 lysate.
Documents
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human ZNF585A shRNA (UAS) - Lentiviral human ZNF585A shRNA (UAS, iRFP) plasmid
